chromium has been researched along with B16 Melanoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, X; Pan, J; Sun, W; Wang, J; Wang, Q; Xia, D; Yu, H; Zhang, L; Zhang, M | 1 |
Eschli, B; Giroglou, T; Matter, M; Mumprecht, S; Ochsenbein, AF; Pavelic, V; Pinschewer, DD; von Laer, D | 1 |
Gold, JE; Osband, ME; Zachary, DT | 1 |
Adema, GJ; de Boer, AJ; Eggert, AA; Figdor, CG; Offringa, R; Schreurs, MW; van Hall, T; Vissers, JL | 1 |
Charak, BS; Mazumder, A; Sadowski, RM | 1 |
5 other study(ies) available for chromium and B16 Melanoma
Article | Year |
---|---|
Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response.
Topics: Adenoviridae; Animals; beta-Galactosidase; CD8-Positive T-Lymphocytes; Chromium; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Female; Injections, Intralesional; Interferon-gamma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nitric Oxide; T-Lymphocytes, Cytotoxic; Tumor Necrosis Factor-alpha | 2005 |
Decreased tumor surveillance after adoptive T-cell therapy.
Topics: Animals; Antigen-Presenting Cells; Chromium; Dendritic Cells; Epitopes, T-Lymphocyte; Fibrosarcoma; Flow Cytometry; Glycoproteins; Homeodomain Proteins; Humans; Immunotherapy, Adoptive; Interferon-gamma; Lymphocytes, Tumor-Infiltrating; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nucleoproteins; Peptide Fragments; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Viral Proteins | 2007 |
Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Topics: Animals; Carcinoma; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chromium; Chromium Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Evaluation Studies as Topic; Immunologic Memory; Immunophenotyping; Immunotherapy, Adoptive; Interferon-gamma; Lymphocyte Activation; Lymphocyte Count; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Sensitivity and Specificity; T-Lymphocyte Subsets; T-Lymphocytes | 1995 |
Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.
Topics: Amino Acid Sequence; Animals; Antigens; Cells, Cultured; Chromatography, High Pressure Liquid; Chromium; Dendritic Cells; Dose-Response Relationship, Drug; Epitopes; Genes, MHC Class I; Humans; Inhibitory Concentration 50; Major Histocompatibility Complex; Male; Melanocytes; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mutation; Peptides; Plasmids; T-Lymphocytes, Cytotoxic; Time Factors; Tumor Cells, Cultured | 2000 |
Antitumor effect of interferon plus cyclosporine A following chemotherapy for disseminated melanoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chromium; Cisplatin; Cyclosporine; Dacarbazine; Drug Synergism; Female; Immunotherapy, Adoptive; Interferons; Major Histocompatibility Complex; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Spleen; T-Lymphocytes, Regulatory | 1992 |